Acorah Software Products - Accounts Production 16.2.850 false true 31 July 2023 1 August 2022 false true No description of principal activity 1 August 2023 31 July 2024 31 July 2024 11477337 Mr Victor Odumosu iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11477337 2023-07-31 11477337 2024-07-31 11477337 2023-08-01 2024-07-31 11477337 frs-core:CurrentFinancialInstruments 2024-07-31 11477337 frs-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 11477337 frs-bus:FilletedAccounts 2023-08-01 2024-07-31 11477337 frs-bus:Micro-entities 2023-08-01 2024-07-31 11477337 frs-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 11477337 frs-bus:Director1 2023-08-01 2024-07-31 11477337 2022-07-31 11477337 2023-07-31 11477337 2022-08-01 2023-07-31 11477337 frs-core:CurrentFinancialInstruments 2023-07-31
Registered number: 11477337
Tvg Pharma Ltd
Unaudited Financial Statements
For The Year Ended 31 July 2024
Balance Sheet
Registered number: 11477337
2024 2023
£ £
Fixed assets 610 125
Current assets 28,161 105,077
Creditors: Amounts Falling Due Within One Year (11,798 ) (43,356 )
NET CURRENT ASSETS 16,363 61,721
TOTAL ASSETS LESS CURRENT LIABILITIES 16,973 61,846
NET ASSETS 16,973 61,846
CAPITAL AND RESERVES 16,973 61,846

Notes

1. General Information
Tvg Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11477337 . The registered office is 49 Oldham Rise, Medbourne, Milton Keynes, MK5 6GE.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2023: 2)
3 2
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Victor Odumosu
Director
27/08/2024